AKO-002, or AKO002, is a combination of the non-selective serotonin receptor agonist and serotonergic psychedelic psilocybin and an undisclosed "specific plant bioactive" which is under development for the treatment of Alzheimer's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.